Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?
Read Full NewsFindings from a phase 2 trial highlighted lacosamide's effectiveness and safety in treating neonatal seizures, showing significant seizure reduction and tolerability in patients.
Here's some of what is coming soon to NeurologyLive® this week.
Ovid Therapeutics' OV329 shows promise as a safe, effective GABA-AT inhibitor for treating drug-resistant seizures, with strong phase 1 trial results.
FDA-approved RBL shows 95% success and sustained microbiome restoration in recurrent C. difficile.
5 Pulmonology Headlines You Missed in November 2025
Adjunctive Lumateperone Significantly Improves MDD Symptoms by Day 43
Stage 5 CKD May Reverse Female Survival Advantage
1.
DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance
2.
PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer
3.
Clinical trial is testing whether heavy lifting could combat cancer side effects
4.
Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.
5.
Cancer cells with thick glycocalyx barrier evade immune system better: study
1.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
2.
The Importance of Early Detection in Skin Cancer: Why Regular Skin Exams Matter
3.
AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology
4.
The New Era of Oncology: Key Updates and Clinical Insights
5.
Examining Serum Osmolality: What It Is And How To Test For It
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge